Gout and its management are of notable significance in Australia. The prevalence of gout in Australia has steadily increased since 1968, 1 and is now reported to be somewhere between 1.6% 1 to 6.8%. 2 Furthermore, at least one in every 100 general practice consults involve patients with gout. 3 The prevalence is even higher in at risk populations, with 16.5% of Australian men over 65 years reported as having gout, 1 and 9.7% of Aboriginal males in certain communities. 4 However, despite its prevalence, in the Australian clinical setting gout is sub-optimally managed. Rates of urate-lowering therapy (ULT) prescription and serum urate monitoring are low, 1,2 and patients report inadequate education regarding gout management from their doctors. 5 Patients also have limited understanding of how to recognize gout flares, and how to manage their medications. 6 Poor patient knowledge hinders effective management, through consequent failure of adherence to lifestyle changes and medications. 7 Australian studies have demonstrated adherence to ULT at 55%, 2 significantly lower than other medications for comparable chronic diseases. 8 Furthermore, clinicians' perceptions that gout is self-inflicted can limit patient care. 9 This highlights the need to study the experiences of patients with gout, to better